Skip to main content

Inside the development of cell and gene therapies

More than 25 cell and gene therapy products have been approved by the FDA, and this burgeoning class of treatments is experiencing its own explosive growth. As more of these potentially curative therapies reach patients, the industry continues to experiment with solutions to grapple with growing pains.

included in this trendline
  • The FDA just approved the first CRISPR drug. Here’s what’s next in gene editing.
  • One biotech’s 3 gene therapy hurdles: delivery, delivery and delivery
  • This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.